CardiacAssist, Inc. announced a rebranding of the privately-held company and will begin to do business as TandemLife as it rolls out several new product lines to hospitals worldwide. Following the FDA clearance of its TandemLung® oxygenator, the new TandemLife company is focused on making advanced cardiac and respiratory support technology available to more patients by providing medical devices that deliver on its mission of Life Support Simplified™.
In North America, less than 2% of patients who experience a cardiac or respiratory emergency currently receive care with advanced cardiopulmonary support, in part because the complexity of such therapy has restricted its use to only the largest, most advanced hospitals. With TandemLife, hospitals can deploy a single pump and controller platform upon which all of the company’s products operate, eliminating the need to train and certify hospital staff on multiple different systems. For cardiac support, a physician may choose the classic TandemHeart procedure, the ProtekDuo procedure available since late 2014, or the new TandemLife procedure, depending on each patient’s individual needs. Likewise, for patients experiencing respiratory dysfunction, either the TandemLife or TandemLung procedures may be appropriate. By offering multiple circulatory support options on a single platform, hospitals can turn to TandemLife as a premier, single-source provider of a comprehensive system to control healthcare costs without sacrificing the quality of care.
More nformation can be found from TandemLife website by clicking this link.
In North America, less than 2% of patients who experience a cardiac or respiratory emergency currently receive care with advanced cardiopulmonary support, in part because the complexity of such therapy has restricted its use to only the largest, most advanced hospitals. With TandemLife, hospitals can deploy a single pump and controller platform upon which all of the company’s products operate, eliminating the need to train and certify hospital staff on multiple different systems. For cardiac support, a physician may choose the classic TandemHeart procedure, the ProtekDuo procedure available since late 2014, or the new TandemLife procedure, depending on each patient’s individual needs. Likewise, for patients experiencing respiratory dysfunction, either the TandemLife or TandemLung procedures may be appropriate. By offering multiple circulatory support options on a single platform, hospitals can turn to TandemLife as a premier, single-source provider of a comprehensive system to control healthcare costs without sacrificing the quality of care.
More nformation can be found from TandemLife website by clicking this link.
No comments:
Post a Comment